| 890 |
Vagus nerve stimulation paired with rehabilitation for upper limb motor function after ischaemic stroke (VNS-REHAB): a random
|
2021-04-30 |
1,426 |
| 889 |
SARS-CoV-2 and Stroke Characteristics
|
2021-04-30 |
1,259 |
| 888 |
Short-term Cessation of Dabigatran Causes a Paradoxical Prothrombotic State
|
2021-04-30 |
1,253 |
| 887 |
Safety and efficacy of intensive blood pressure lowering after successful endovascular therapy in acute ischaemic stroke (BP-
|
2021-03-31 |
2,023 |
| 886 |
Importance of Occlusion site for Thrombectomy
|
2021-03-31 |
1,665 |
| 885 |
Brain disconnections link structural connectivity with function and behavior
|
2021-03-31 |
1,681 |
| 884 |
Magnetic Resonance Imaging–Guided Thrombolysis (0.6 mg/kg) Was Beneficial for Unknown Onset Stroke Above a Certain Core Size
|
2021-01-28 |
2,596 |
| 883 |
Prediction of Early Neurological Deterioration in Individuals with Minor Stroke and Large Vessel Occlusion Intended for Intra
|
2021-01-28 |
6,560 |
| 882 |
Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve
|
2020-12-28 |
1,655 |
| 881 |
Multimodal Neuroimaging Using Concurrent EEG/fNIRS for Poststroke Recovery Assessment: An Exploratory Study
|
2020-12-28 |
1,619 |
| 880 |
Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systemic review and meta-analysis of
|
2020-12-28 |
1,990 |
| 879 |
Patterns of use and discontinuation of secondary prevention medications after stroke
|
2020-11-30 |
1,637 |
| 878 |
Clinical Course of Acute Ischemic Stroke Due to Medium Vessel Occlusion With and Without Intravenous Alteplase Treatment
|
2020-11-26 |
2,071 |
| 877 |
Admission Blood Pressure in Relation to Clinical Outcomes and Successful Reperfusion After Endovascular Stroke Treatment
|
2020-11-26 |
1,668 |
| 876 |
Safety and efficacy of fluoxetine on functional recovery after acute stroke (EFFECTS): a randomized, double-blind, placebo-co
|
2020-10-30 |
1,651 |
HOME
LOGIN
